JVMSX | PMVQX | JVMSX / PMVQX | |
Total Expense Ratio | 1.25 | 0.73 | 171% |
Annual Report Gross Expense Ratio | 1.26 | 0.88 | 143% |
Fund Existence | 13 years | 15 years | - |
Gain YTD | 8.728 | 5.607 | 156% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.6B | 163M | 14,479% |
Annual Yield % from dividends | 0.41 | 1.76 | 23% |
Returns for 1 year | 0.34 | 8.96 | 4% |
Returns for 3 years | 10.96 | 18.90 | 58% |
Returns for 5 years | 48.09 | 92.52 | 52% |
Returns for 10 years | 41.60 | 43.08 | 97% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HGHIX | 36.34 | 0.54 | +1.51% |
Hartford Healthcare I | |||
FCGPX | 20.78 | 0.04 | +0.19% |
NYLI PineStone Global Equity Class P | |||
SUVZX | 13.18 | -0.05 | -0.38% |
PGIM Quant Solutions Large-Cap Val Z | |||
PASVX | 53.27 | -0.23 | -0.43% |
T. Rowe Price Small-Cap Value Adv | |||
JORSX | 16.29 | -0.10 | -0.61% |
JHancock Small Cap Core R6 |